Dicerna Pharmaceuticals, Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Dicerna Pharmaceuticals, Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Dicerna Pharmaceuticals, Inc. stocks after a simple registration process. </div>

Q: How to buy Dicerna Pharmaceuticals, Inc. shares in India?

<div> To buy Dicerna Pharmaceuticals, Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Dicerna Pharmaceuticals, Inc. and you are done!</div> </div>

Q: What is the share price of Dicerna Pharmaceuticals, Inc.?

<div>The share price of Dicerna Pharmaceuticals, Inc. is USD 38.22 as on 28 Dec.</div>

Q: What is the Market Capitalization of Dicerna Pharmaceuticals, Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Dicerna Pharmaceuticals, Inc. is USD 2.98B as on 28 Dec.</div>

Q: What is the PE ratio of Dicerna Pharmaceuticals, Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Dicerna Pharmaceuticals, Inc. is N/A as on 28 Dec. </div>

Q: Is Dicerna Pharmaceuticals, Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Dicerna Pharmaceuticals, Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Dicerna Pharmaceuticals, Inc. operate?

<div> Dicerna Pharmaceuticals, Inc. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$38.22

(28 Dec)

Loading Chart

Previous close

$38.22

Open

$38.22

Today’s high

$38.24

Today’s low

$38.21

52W low

$19.06

52W high

$40.14

51.49%

EPS (TTM)

-1.63

Shares O/S

72.10M

Market cap

2.98B

Insights

DRNA has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.

DRNA price is above its 200 day moving average

In beta. Send feedback here.

Compare with other stock

About Dicerna Pharmaceuticals, Inc.

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to silence selectively genes that cause or contribute to disease. The Company's GalXC RNAi technology Platform consists of its liver-targeted GalXC technology and GalXC-Plus technology for tissues outside the liver.

The Company's product line includes nedosiran, RG6346, belcesiran, and DCR-AUD. Its lead product candiadate nedosiran is a RNAi drug candidate developed for the treatment of hyperoxaluria (PH). The RG6346 for the treatment of chronic hepatitis B virus (HBV) infection. The belcesiran for the treatment of alpha-1 antitrypsin deficiency-associated liver disease (AATLD). The DCR-AUD for the treatment of alcohol use disorder (AUD). .

FAQs

Can I buy Dicerna Pharmaceuticals, Inc. shares in India?

How to buy Dicerna Pharmaceuticals, Inc. shares in India?

What is the share price of Dicerna Pharmaceuticals, Inc.?

What is the Market Capitalization of Dicerna Pharmaceuticals, Inc.?

What is the PE ratio of Dicerna Pharmaceuticals, Inc.?

Is Dicerna Pharmaceuticals, Inc. a good stock to buy?

In which sector / industry does Dicerna Pharmaceuticals, Inc. operate?